Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Vega

Showing results (81-90 of 214) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicityMahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Breast Cancer Research and Treatment|October 25, 2014
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancersJon Zugazagoitia, Pedro Pérez-Segura, Arancha Manzano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2013
Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancerSarah L Kerns, Richard G Stock, Nelson N Stone, et al.
Frontiers in Genetics|September 21, 2018
Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?Alejandro Moles-Fernández, Laura Duran-Lozano, Gemma Montalban, et al.
Frontiers in Oncology|May 13, 2017
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers EraDavid Azria, Ariane Lapierre, Sophie Gourgou, et al.
Human Mutation|September 13, 2013
Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility allelesAna Osorio, Massimo Bogliolo, Victoria Fernández, et al.
Ejhaem|November 29, 2023
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima)Ernesto Pérez-Persona, Laida Cuevas Palomares, Ariane Unamunzaga Cilaurren, et al.
European Journal of Haematology|February 23, 2022
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75-year-olds newly diagnosed with multiple myelomaErnesto Pérez-Persona, Itziar Oiartzabal-Ormategui, Susana Herraez, et al.
Clinical Chemistry|December 6, 2020
A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer PatientsLidia Feliubadaló, Alejandro Moles-Fernández, Marta Santamariña-Pena, et al.
The Journal of Molecular Diagnostics : JMD|October 21, 2023
A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical AnalysisLuz-Marina Porras, Natàlia Padilla, Alejandro Moles-Fernández, et al.
Pageof 22

Showing results (81-90 of 214) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicityMahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Breast Cancer Research and Treatment|October 25, 2014
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancersJon Zugazagoitia, Pedro Pérez-Segura, Arancha Manzano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2013
Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancerSarah L Kerns, Richard G Stock, Nelson N Stone, et al.
Frontiers in Genetics|September 21, 2018
Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?Alejandro Moles-Fernández, Laura Duran-Lozano, Gemma Montalban, et al.
Frontiers in Oncology|May 13, 2017
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers EraDavid Azria, Ariane Lapierre, Sophie Gourgou, et al.
Human Mutation|September 13, 2013
Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility allelesAna Osorio, Massimo Bogliolo, Victoria Fernández, et al.
Ejhaem|November 29, 2023
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima)Ernesto Pérez-Persona, Laida Cuevas Palomares, Ariane Unamunzaga Cilaurren, et al.
European Journal of Haematology|February 23, 2022
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75-year-olds newly diagnosed with multiple myelomaErnesto Pérez-Persona, Itziar Oiartzabal-Ormategui, Susana Herraez, et al.
Clinical Chemistry|December 6, 2020
A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer PatientsLidia Feliubadaló, Alejandro Moles-Fernández, Marta Santamariña-Pena, et al.
The Journal of Molecular Diagnostics : JMD|October 21, 2023
A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical AnalysisLuz-Marina Porras, Natàlia Padilla, Alejandro Moles-Fernández, et al.
Pageof 22